Special Issue "Regulation and Control of Intracellular Signalling"

A special issue of Processes (ISSN 2227-9717). This special issue belongs to the section "Biological Processes and Systems".

Deadline for manuscript submissions: 10 October 2022 | Viewed by 2338

Special Issue Editors

Dr. Jinwei Zhang
E-Mail Website
Guest Editor
Medical School, University of Exeter, Exeter EX4 4PS, UK
Interests: kinase signaling; ion transporters; chloride homeostasis; disease mechanism; drug discovery; biotechnology
Prof. Dr. Ke Ding
E-Mail Website
Guest Editor
School of Pharmacy, Jinan University, Guangzhou 510632, China
Interests: medicinal chemistry; drug-like molecules; pharmacology; signalling transduction
Prof. Dr. Dandan Sun
E-Mail Website
Guest Editor
Department of Neurology, University of Pittsburgh Medical Cente, Pittsburgh, PA 15213, USA
Interests: signalling transductino; ion transporters; disease mechaism; brain disorders

Special Issue Information

Dear Colleagues,

Almost all aspects of cellular processes and functions are dependent on intracellular signalling initiated at the cell surface. The response of cells to signalling molecules, e.g., growth factors, is determined by their complement of expressed receptors and pathways that transduce and transmit these signals to intracellular compartments; and the enzymes, ion channels/transporters, and cytoskeletal proteins that ultimately mediate the effects of the signalling molecules. Several primary classes of signalling systems either comprise ligand-gated ion channels or consist of receptor tyrosine kinases or utilise G protein-linked signals in a multistep process, operating at different time courses from milliseconds to minutes, providing great flexibility for intercellular communication. In most cases, the initial steps in the signalling system typically generate a second messenger inside the cell, and this second messenger then activates a number of proteins, including protein kinases that modify cellular processes. Intracellular signal transduction may target transcription factors that function to regulate gene expression and connect the cell surface to the nucleus, thus determining the differentiated and functional state of cells, or in response to extracellular stimuli. Abnormalities in these pathways cause many diseases, including hypertension, cancer, diabetes, neurodegeneration and inflammation, etc. Deciphering how disruptions in signalling networks lead to disease will reveal novel drug targets and improved strategies to treat these maladies.

This Special Issue on “Regulation and Control of Intracellular Signalling” aims to curate novel advances in deciphering intracellular signalling networks for drug discovery and disease treatment. Topics include but are not limited to:

  • New intracellular signalling networks that are genetically and epigenetically altered in human diseases, leading to constitutive pathway activation or suppression;
  • New “-omic” technologies or high-throughput methods to reveal molecular interactions in a real and quantitative way within intracellular signalling networks;
  • New compounds that selectively inhibit altered proteins that are critical for the maintenance of the transformed phenotype and which have shown unprecedented clinical activity in genetically defined subsets of diseases;
  • New computational approaches towards signal transduction pathways.

Dr. Jinwei Zhang
Prof. Dr. Ke Ding
Prof. Dr. Dandan Sun
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Processes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cellular processes and functions
  • intracellular signalling networks
  • ligand-gated ion channels
  • kinases
  • G protein-linked signals
  • signalling transduction
  • computational modelling
  • drug discovery

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Article
An ATM/CHK2 Signaling Pathway Induces Nuclear Translocation of SRPK2 in Cisplatin-Treated HeLa Cells
Processes 2021, 9(12), 2223; https://doi.org/10.3390/pr9122223 - 09 Dec 2021
Viewed by 825
Abstract
Chemotherapeutic agents are frequently used to treat various cancers, but the mechanisms mediating the cellular response to the drugs are still not fully understood. We previously reported that the nuclear translocation of serine/arginine protein kinases (SRPKs), triggered by the exposure of cells to [...] Read more.
Chemotherapeutic agents are frequently used to treat various cancers, but the mechanisms mediating the cellular response to the drugs are still not fully understood. We previously reported that the nuclear translocation of serine/arginine protein kinases (SRPKs), triggered by the exposure of cells to DNA damage-inducers, plays a pivotal role in drug responsiveness. Here, we investigated the mechanism linking the nuclear accumulation of SRPK2 to the cisplatin treatment of HeLa cells. We present experimental evidence that nuclear SRPK2 acts downstream of Chk2 in the ATM/Chk2 cascade. The inhibition of ATM or Chk2 kinase activity by specific low-molecular-weight inhibitors restricted SRPK2 to the cytoplasm and conferred tolerance to cisplatin treatment. A similar effect was achieved by treating cells with SRPIN340, a selective SRPK1/2 inhibitor, thus confirming previous findings that kinase activity is indispensable for the nuclear import of SRPKs. These data add to previous findings that support a decisive role of SRPKs in coordinating cellular response to DNA damage. Full article
(This article belongs to the Special Issue Regulation and Control of Intracellular Signalling)
Show Figures

Figure 1

Article
Heparanase (HPSE) Associates with the Tumor Immune Microenvironment in Colorectal Cancer
Processes 2021, 9(9), 1605; https://doi.org/10.3390/pr9091605 - 07 Sep 2021
Viewed by 609
Abstract
There is an unmet clinical need to identify potential predictive biomarkers for immunotherapy efficacy in mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC). Heparanase (HPSE) is a multifunctional molecule mediating tumor–host crosstalk. However, the function of HPSE in the tumor immune microenvironment of [...] Read more.
There is an unmet clinical need to identify potential predictive biomarkers for immunotherapy efficacy in mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC). Heparanase (HPSE) is a multifunctional molecule mediating tumor–host crosstalk. However, the function of HPSE in the tumor immune microenvironment of CRC remains unclear. Data of CRC patients from public datasets (TCGA and GSE39582) and Zhongshan Hospital (ZS cohort) were collected to perform integrative bioinformatic analyses. In total, 1036 samples from TCGA (N = 457), GSE39582 (N = 510) and ZS cohort (N = 69) were included. Samples of deficient MMR (dMMR) and consensus molecular subtypes 1 (CMS1) showed significantly higher HPSE expression. The expression of HPSE also exhibited a significantly positive association with PD-L1 expression, tumor mutation burden and the infiltration of macrophages. Immune pathways were remarkably enriched in the HPSE high-expression group, which also showed higher expressions of chemokines and immune checkpoint genes. Survival analysis suggested that high HPSE expression tended to be associated with shorter overall survival in patients with pMMR mCRC. HPSE might contribute to the immune-activated tumor microenvironment with high levels of immune checkpoint molecules, suggesting that pMMR mCRC with high HPSE expression might respond to immune checkpoint inhibitors. Full article
(This article belongs to the Special Issue Regulation and Control of Intracellular Signalling)
Show Figures

Figure 1

Back to TopTop